Asylia Therapeutics
Business Services · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2450 Holcombe Blvd Ste J, Houston, Texas...Website
www.asyliatx.comRevenue
$5 MillionIndustry
About Asylia Therapeutics
Asylia Therapeutics Org Chart
Is Asylia Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Asylia Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Asylia Therapeutics
Asylia Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Asylia Therapeutics has new funding data
Product Launch: Get notified when Asylia Therapeutics launches new products
Earning: See what the market has to say on Asylia Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Asylia Therapeutics is spiking on competitors!
Check if Asylia Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Asylia Therapeutics
Compare insights from companies similar to Asylia Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Asylia Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Asylia Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Asylia Therapeutics.
Asylia Therapeutics financials insights
Gather financial insights about Asylia Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$14.5M
Asylia Therapeutics Tech Stack
A closer look at the technologies used by Asylia Therapeutics
Asylia Therapeutics News & Media
Biotech firm Stellanova Therapeutics closes $15.5M Series A, names CEO
The firm's founding CEO previously led Johnson & Johnson's JLABS incubator at the Texas Medical Center.Biotech firm Asylia Therapeutics raises $14.5M, names founding CEO
A Houston-based biotechnology firm with multiple clinical assets targeting cancer and autoimmune diseases raised a $14.5 million round.Asylia Therapeutics, Inc. Announces Closing of $14.5 Million Series A Financing
Proceeds will support development of novel antibody drugs that convert immunologically “cold” tumors into treatable “hot” tumors, with the goal of enhancing effectiveness of cancer immunotherapy Proceeds will support development of novel antibody drugs that convert immunologically “cold” tumors into treatable “hot” tumors, with the goal of enhancing effectiveness of cancer immunotherapy
Top Business Services Companies
Frequently Asked Questions Regarding Asylia Therapeutics
Founded in 2019, Asylia Therapeutics is a private development stage biotechnology company committed to transforming scientific advances into safe and effective medicines for cancer, autoimmune and infectious diseases. The company is headquartered in Houston, Texas.... Read More